GlassScriptPhysician profile
David A Anderson
NPI 1477594505
$10,707.93
in general payments reported to CMS, 2019-2025
32 companies · $429 in 2025
The $429 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,628 · 2020: $848 · 2021: $3,063 · 2022: $2,099 · 2023: $1,765 · 2024: $877 · 2025: $429.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,666 · Travel and Lodging: $342 · Education: $46.41 · Gift: $16.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,666.02 |
| Travel and Lodging | $342.39 |
| Education | $46.41 |
| Gift | $16.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $4,543.44 | 2020-2024 | Axonics, Bulkamid |
| Intuitive Surgical, INC. | $2,964.18 | 2020-2024 | Da Vinci Surgical System |
| Neotract INC. | $1,081.64 | 2019 | |
| Boston Scientific Corporation | $620.85 | 2019-2025 | Embold Fibered, Advance Xp, Clinical Trial Product |
| Astellas Pharma US INC | $345.12 | 2019-2024 | Myrbetriq, Veozah |
| Abbvie INC. | $106.76 | 2019-2025 | |
| Amgen INC. | $99.89 | 2019-2025 | Tezspire |
| Calyxo, INC. | $91.62 | 2024-2025 | Cvac Aspiration System |
| Ethicon INC. | $77.80 | 2022 | |
| Urogen Pharma, INC. | $77.64 | 2024-2025 | |
| Myriad Genetic Laboratories, INC. | $77.42 | 2023 | Prolaris |
| Ferring Pharmaceuticals INC. | $69.48 | 2025 | Adstiladrin |
| Vertex Pharmaceuticals Incorporated | $66.21 | 2024-2025 | |
| Tolmar, INC. | $54.16 | 2023-2024 | |
| Teleflex LLC | $40.80 | 2024 | Urolift |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $37.46 | 2019-2020 | |
| Coloplast Corp | $35.44 | 2021-2025 | |
| Astrazeneca Pharmaceuticals LP | $35.06 | 2025 | Imfinzi |
| Janssen Biotech, INC. | $34.51 | 2019-2025 | Erleada |
| Sumitomo Pharma America, INC. | $31.86 | 2023-2024 | Orgovyx, Gemtesa |
| Tolmar Pharmaceuticals, INC. | $29.17 | 2019 | |
| Medtronic, INC. | $24.96 | 2025 | Altaviva |
| Novartis Pharmaceuticals Corporation | $23.57 | 2024 | |
| Procept Biorobotics Corporation | $23.15 | 2022 | |
| Karl Storz Endoscopy-America | $17.99 | 2024 | |
| Civco Medical Instruments | $17.09 | 2025 | |
| Blue Earth Diagnostics | $16.73 | 2020 | |
| Photocure INC | $14.46 | 2023 | Cysview |
| Olympus America INC. | $13.61 | 2019 | |
| Davol INC. | $13.15 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $11.36 | 2019 | |
| Travere Therapeutics, INC. | $11.35 | 2025 | Thiola |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Anderson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.